Journal Watch · European Heart Journal · 2026
Deep learning electrocardiogram model for risk stratification of coronary revascularization need in the emergency department.
The ECG model had higher specificity but lower sensitivity compared with high-sensitivity-troponin T.<h4>Conclusions</h4>The model was able to detect revascularization and Type 1 MI with competitive performance, suggesting a potential role to complement current clinical assessment.
TL;DR
The ECG model had higher specificity but lower sensitivity compared with high-sensitivity-troponin T.<h4>Conclusions</h4>The model was able to detect revascularization and Type 1 MI with competitive performance, suggesting a potential role to complement current clinical assessment.
Key findings
- In the external validation cohort, ECG model AUROC was 0.81 (95% CI 0.81-0.82) for revascularization, and 0.85 (95% CI 0.84-0.85) for Type 1 MI, compared with 0.70 (95% CI 0.57-0.83) and 0.74 (95% CI 0.56-0.92) for clinician interpretation, and 0.85 and 0.87 for high-sensitivity (hs)-TnT, respectively.
- The ECG model had higher specificity but lower sensitivity compared with high-sensitivity-troponin T.<h4>Conclusions</h4>The model was able to detect revascularization and Type 1 MI with competitive performance, suggesting a potential role to complement current clinical assessment.
Numbers at a glance (from the abstract)
Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.
What they did
External validation was performed for the outcomes revascularization and Type 1 myocardial infarction (MI) on 18 673 ED visits from Europe (55 ± 21 years; 49% female; 1.5% revascularization; 1% Type 1 MI). Primary performance metric was area under the receiver operating characteristic curve (AUROC).<h4>Results</h4>In the test cohort, the model achieved an AUROC of 0.91 (95% confidence interval [CI] 0.91-0.91), outperforming clinician ECG interpretation (AUROC 0.65, 95% CI 0.54-0.76) and conventional cardiac TnT (AUROC 0.71).
Full abstract (original)
Background: <h4>Background and aims</h4>Identification of patients with acute coronary syndrome requiring coronary revascularization can be challenging due to inconclusive electrocardiogram (ECG) findings or biomarker results. A deep learning model to detect ECG patterns associated with revascularization likelihood was developed, aiming to guide further assessment and reduce diagnostic uncertainty.<h4>Methods</h4>A convolutional neural network model was trained on 144 691 ED visits from a US cohort (60 ± 19 years; 53% female; 0.6% revascularization), tested on a separate test cohort (n = 35 995), and benchmarked against clinician ECG interpretation and cardiac troponin T (TnT).
What they did: External validation was performed for the outcomes revascularization and Type 1 myocardial infarction (MI) on 18 673 ED visits from Europe (55 ± 21 years; 49% female; 1.5% revascularization; 1% Type 1 MI). Primary performance metric was area under the receiver operating characteristic curve (AUROC).<h4>Results</h4>In the test cohort, the model achieved an AUROC of 0.91 (95% confidence interval [CI] 0.91-0.91), outperforming clinician ECG interpretation (AUROC 0.65, 95% CI 0.54-0.76) and conventional cardiac TnT (AUROC 0.71).
Results & conclusions: In the external validation cohort, ECG model AUROC was 0.81 (95% CI 0.81-0.82) for revascularization, and 0.85 (95% CI 0.84-0.85) for Type 1 MI, compared with 0.70 (95% CI 0.57-0.83) and 0.74 (95% CI 0.56-0.92) for clinician interpretation, and 0.85 and 0.87 for high-sensitivity (hs)-TnT, respectively. The ECG model had higher specificity but lower sensitivity compared with high-sensitivity-troponin T.<h4>Conclusions</h4>The model was able to detect revascularization and Type 1 MI with competitive performance, suggesting a potential role to complement current clinical assessment.
Abstract © the authors / European Heart Journal (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1093/eurheartj/ehaf254 · PubMed 40156923.
Why it matters for pharma & biotech
- Directly relevant to teams in AI in drug discovery / diagnostics — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
- Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Modalities & themes detected: AI in drug discovery / diagnostics
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
Frequently asked questions
What did this European Heart Journal study find?
The ECG model had higher specificity but lower sensitivity compared with high-sensitivity-troponin T.<h4>Conclusions</h4>The model was able to detect revascularization and Type 1 MI with competitive performance, suggesting a potential role to complement current clinical assessment.
What type of study is this?
It is a cohort / observational clinical study, published in European Heart Journal in 2026. External validation was performed for the outcomes revascularization and Type 1 myocardial infarction (MI) on 18 673 ED visits from Europe (55 ± 21 years; 49% female; 1.5% revascularization; 1% Type 1 MI).
Where can I read the original paper?
The original is at the publisher via DOI 10.1093/eurheartj/ehaf254. PubMed ID: 40156923. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/deep-learning-electrocardiogram-model-for-risk-stratification-of-coronar-haf254/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides